CoChat

Energy metabolism transition in multi‐cellular human tumor spheroids

Rodríguez‐Enríquez, Sara, Gallardo‐Pérez, Juan Carlos, Avilés‐Salas, Alejandro, Marín‐Hernández, Alvaro, Carreño‐Fuentes, Liliana, Maldonado‐Lagunas, Vilma, Moreno‐Sánchez, Rafael · 2008 · Journal of Cellular Physiology
Cited by 135

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

It is thought that glycolysis is the predominant energy pathway in cancer, particularly in solid and poorly vascularized tumors where hypoxic regions develop. To evaluate whether glycolysis does effectively predominate for ATP supply and to identify the underlying biochemical mechanisms, the glycolytic and oxidative phosphorylation (OxPhos) fluxes, ATP/ADP ratio, phosphorylation potential, and expression and activity of relevant energy metabolism enzymes were determined in multi‐cellular tumor spheroids, as a model of human solid tumors. In HeLa and Hek293 young‐spheroids, the OxPhos flux and cytochrome c oxidase protein content and activity were similar to those observed in monolayer cultured cells, whereas the glycolytic flux increased two‐ to fourfold; the contribution of OxPhos to ATP supply was 60%. In contrast, in old‐spheroids, OxPhos, ATP content, ATP/ADP ratio, and phosphorylation potential diminished 50–70%, as well as the activity (88%) and content (3 times) of cytochrome c oxidase. Glycolysis and hexokinase increased significantly (both, 4 times); consequently glycolysis was the predominant pathway for ATP supply (80%). These changes were associated with an increase (3.3 times) in the HIF‐1α content. After chronic exposure, both oxidative and glycolytic inhibitors blocked spheroid growth, although the glycolytic inhibitors, 2‐deoxyglucose and gossypol (IC 50 of 15–17 nM), were more potent than the mitochondrial inhibitors, casiopeina II‐gly, laherradurin, and rhodamine 123 (IC 50 > 100 nM). These results suggest that glycolysis and OxPhos might be considered as metabolic targets to diminish cellular proliferation in poorly vascularized, hypoxic solid tumors. J. Cell. Physiol. 216: 189–197, 2008. © 2008 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcp.21392

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 135

Metadata

Authors
Rodríguez‐Enríquez, S., Gallardo‐Pérez, J. C., Avilés‐Salas, A., Marín‐Hernández, A., Carreño‐Fuentes, L., Maldonado‐Lagunas, V., & Moreno‐Sánchez, R.
Venue
Journal of Cellular Physiology
Publisher
Wiley
Published
2008-02-08
Volume
216
Issue
1
Pages
189-197
ISSN
  • 0021-9541 (ISSN-L)
  • 1097-4652
OpenAlex
W2159967184
Cited by
135
References
11
FWCI
2.73
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.